Hims & Hers Completes Acquisition of Eucalyptus, Advancing Position as the World's Largest Consumer Health Platform
Stocks in this Quantisnow insightHealth Care
Historical context for HIMS
Across the 23 sessions after earlier HIMS headlines, the stock closed higher 13 times and lower 10 times, with a median move of 4.2% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | HIMS | SPY |
|---|---|---|---|
| May 28, 2026 | Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners | +0.7% | +0.6% |
| May 21, 2026 | Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutideand 1 other headline that session | +4.2% | +0.2% |
| May 19, 2026 | Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment | +0.7% | -0.7% |
| May 18, 2026 | Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment | -11.0% | -0.1% |
| May 12, 2026 | Needham reiterated coverage on Hims & Hers Health with a new price targetand 1 other headline that session | -14.1% | -0.2% |
| Apr 28, 2026 | Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors | -5.0% | -0.5% |
Quantisnow market dataNYSE
HIMS
Hims & Hers Health Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- Listed since
- 2019
Get push alerts for HIMS
Full HIMS profile on Quantisnow Follow HIMS and get a push notification the moment its next story breaks.